Lv1
50 积分 2024-10-09 加入
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: The EPIC-Norfolk Prospective Population study
2个月前
已完结
Trastuzumab-Induced Cardiotoxicity: When and How Much Should We Worry?
2个月前
已完结
New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity
2个月前
已完结
Immune Checkpoint Inhibitor–Induced Cardiotoxicity
2个月前
已完结
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2个月前
已完结
Immune responses in checkpoint myocarditis across heart, blood and tumour
2个月前
已完结
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
2个月前
已完结
Heart failure with preserved ejection fraction: everything the clinician needs to know
2个月前
已完结
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
4个月前
已完结
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review
5个月前
已完结
皖公网安备34019202002308
